Generally, the Japanese guidelines for treatment include treatment of thyrotoxicosis (reduction in thyroid hormone secretion and production), management of systemic manifestations (fever, dehydration, shock), organ-specific manifestations (cardiovascular, neurological, and hepatic-gastrointestinal), triggers, and definitive therapy [247]. This evidence concerns the gene TG and thyrotoxicosis.